An open label, single dose, randomized, three period crossover study to investigate the relative bioavailability of 0.5 mg of dutasteride from soft gelatin capsules (reference) vs. soft gelatin capsules containing two investigational formulations in healthy male volunteers
Latest Information Update: 20 Aug 2023
At a glance
- Drugs Dutasteride (Primary)
- Indications Benign prostatic hyperplasia; Prostate cancer; Prostatic intraepithelial neoplasia
- Focus Pharmacokinetics
- Sponsors GlaxoSmithKline; GSK
- 07 Jun 2007 New trial record.